ArticleNeurocritical care2026
Arterial Spin Labeling of Cerebral Perfusion in Unresponsive Wakefulness Syndrome: A Proof-of-Concept Comparison with FDG-PET.
Article in Neurocritical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundDespite the clinical utility of [
methodsThis prospective observational study included 33 participants with UWS (10 female; mean age, 49.48 ± 14.9 years) and 17 healthy controls (HCs) (9 female; mean age, 31.9 ± 9.6 years). Participants underwent FDG-PET and ASL scans to measure metabolism (via glucose uptake) and cerebral blood flow (CBF), respectively. CBF and metabolism in the UWS and HC cohorts were compared, globally and for seven functional networks. Comparability of the two modalities was estimated using partial correlation for both global and network levels. Crossmodal validation was further performed by testing the generalizability of machine learning classifiers trained on ASL data to positron emission tomography (PET) data and, conversely, classifiers trained on PET data to ASL data.
resultsASL revealed decreased CBF in patients with UWS relative to HCs, consistent with reductions in glucose metabolism observed for FDG-PET. Positive correlations were observed between CBF and metabolism across the global brain and most networks. Crossmodal validation demonstrated correspondence and complementary discriminatory information between ASL and PET data.
conclusionsOur results provide proof-of-concept evidence that ASL is comparable to and complementary with FDG-PET; together with the practical advantages of ASL, these findings support further investigation of ASL in the clinical assessment of UWS.
Indexed as
Identifiers
42509477What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.